Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy
-
* Corresponding authors: Aladar A Szalay aaszalay@genelux.com - Francesco M Marincola Fmarincola@mail.cc.nih.gov
BMC Genomics 2009, 10:301 doi:10.1186/1471-2164-10-301
Accesses
- Last 30 days: 63 accesses
- Last 365 days: 843 accesses
- All time: 2852 accesses